News from debiopharm group A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Jun 07, 2016, 11:14 ET Debiopharm International SA Initiates Clinical Phase II Study Evaluating Debio 1143 in Ovarian Cancer

Debiopharm International SA (Debiopharm), part of Debiopharm Group™, a Swiss-based global biopharmaceutical company, today...


Jun 02, 2016, 03:00 ET FDA Grants Orphan Drug Designation to Debiopharm International SA's IAP Inhibitor Debio 1143 in the Treatment of Ovarian Cancer

Debiopharm International SA (Debiopharm), a Swiss-based company, part of Debiopharm Group™, today announced that the FDA Office of...


May 11, 2016, 08:00 ET Debiopharm Group™ Donates to IMD to Promote Best Practice in Family Business Philanthropy

Family businesses comprise upwards of 70% of companies worldwide and contribute extensively to the global economy and philanthropy today. However...


Apr 15, 2016, 03:00 ET Debiopharm International SA Announces Presentation at AACR of Non-clinical Data Relating to its Targeted Investigational Compound Debio 1347/CH5183284, a Selective FGFR 1,2,3 Inhibitor

Debiopharm International SA (Debiopharm), a Swiss-based company, part of Debiopharm Group™, today announces that...


Apr 08, 2016, 03:00 ET Debiopharm International SA to Present the Latest Findings on Debio 1450 at ECCMID

Debiopharm will be present at ECCMID in Amsterdam to share new data supporting the clinical development of its first in class...


Mar 04, 2016, 03:00 ET Debiopharm International SA Has Won Its Patent Infringement Suit for Elplat® Against Nippon Kayaku Co., Ltd.

Debiopharm International SA (Debiopharm), part of Debiopharm Group™, a Swiss-based global biopharmaceutical company today...


Jan 13, 2016, 10:00 ET Debiopharm International SA and EORTC Announce a Collaboration to Investigate Triptorelin for Treatment of Salivary Gland Cancers

Debiopharm International SA (Debiopharm), part of Debiopharm Group™, a Swiss-based global biopharmaceutical company, today announced a...


Jan 11, 2016, 09:30 ET Debiopharm International SA and Arbor Pharmaceuticals, LLC Announce Their US Commercialization Partnership for Triptorelin in Central Precocious Puberty

Debiopharm International SA (Debiopharm), part of Debiopharm Group™, a Swiss-based global biopharmaceutical company, and...


Dec 08, 2015, 03:00 ET L'EMA accorde la Désignation de Médicament Orphelin à l'inhibiteur d'IAP Debio 1143 développé par Debiopharm International SA pour le traitement du cancer de l'ovaire

Debiopharm International SA (Debiopharm), partie intégrante de Debiopharm Group™, une société biopharmaceutique...


Dec 08, 2015, 03:00 ET EMA Grants Orphan Drug Designation to Debiopharm International SA's IAP Inhibitor Debio 1143 in the Treatment of Ovarian Cancer

Debiopharm International SA (Debiopharm), part of Debiopharm Group™, a Swiss-based global biopharmaceutical company, today...


Dec 08, 2015, 03:00 ET EMA Grants Orphan Drug Designation to Debiopharm International SA's IAP Inhibitor Debio 1143 in the Treatment of Ovarian Cancer

Debiopharm International SA (Debiopharm), part of Debiopharm Group™, a Swiss-based global biopharmaceutical company, today...


Dec 08, 2015, 03:00 ET L'EMA accorde la Désignation de Médicament Orphelin à l'inhibiteur d'IAP Debio 1143 développé par Debiopharm International SA pour le traitement du cancer de l'ovaire

Debiopharm International SA (Debiopharm), partie intégrante de Debiopharm Group™, une société biopharmaceutique...


Dec 07, 2015, 03:00 ET United Laboratories Inc. and Debiopharm International SA Announce the Launch of Pamorelin® LA in the Philippines

United Laboratories Inc. (Unilab) and Debiopharm International SA (Debiopharm) announce the signature of an exclusive agreement for...


Dec 07, 2015, 03:00 ET United Laboratories Inc. and Debiopharm International SA Announce the Launch of Pamorelin® LA in the Philippines

United Laboratories Inc. (Unilab) and Debiopharm International SA (Debiopharm) announce the signature of an exclusive agreement for...


Nov 24, 2015, 03:00 ET Debiopharm International SA's Partner Yakult Honsha Co, Ltd. Announces Elplat® Approbation in Gastric Cancer in Japan

Debiopharm International SA (Debiopharm), part of Debiopharm Group™, a Swiss-based global biopharmaceutical company, is proud...


Nov 03, 2015, 03:00 ET Debiopharm International SA Presents Positive Preliminary Results From Phase 1 Trials in the Development of the IAP Inhibitor Debio 1143 at the 27th EORTC-NCI-AACR Symposium in Boston

Debiopharm International SA (Debiopharm) - part of Debiopharm Group™, a Swiss-based global biopharmaceutical company - today...


Sep 08, 2015, 03:00 ET Debiopharm International SA und Solid Biosciences, LLC, kündigen Partnerschaft an, um die Anwendung von Alisporivir (Debio 025) bei Muskeldystrophie zu erforschen

Debiopharm startet zusammen mit Solid Biosciences, einem auf DMD spezialisiertes Biotech-Unternehmen, präklinische Tierstudien für...


Sep 08, 2015, 03:00 ET Debiopharm International SA y Solid Biosciences, LLC explorarán el uso de Alisporivir

- Debiopharm International SA y Solid Biosciences, LLC anuncian una colaboración para explorar el uso de Alisporivir (Debio 025) en la...


Sep 08, 2015, 03:00 ET Debiopharm International SA et Solid Biosciences, LLC débutent une collaboration afin d' explorer l'utilisation de l'Alisporivir (Debio 025) dans le traitement de la dystrophie musculaire

Debiopharm initiera des études précliniques pour le traitement de la myopathie de Duchenne (MD) sur des modèles animaux   en...


Sep 08, 2015, 03:00 ET Debiopharm International SA and Solid Biosciences, LLC, Announce a Collaboration to Explore the Use of Alisporivir (Debio 025) in Muscular Dystrophy

Debiopharm to start pre-clinical animal studies in Duchenne Muscular Dystrophy (DMD) with Solid Biosciences, a DMD-focused biotech...


Jun 16, 2015, 08:00 ET Debiopharm International SA fait l'acquisition de la technologie de traitement des échantillons FibroTrap de Spinomix

  - Applicable à divers types d'échantillons pour isoler des bactéries, virus, cellules tumorales,...


Jun 16, 2015, 08:00 ET Debiopharm International SA Acquires FibroTrap Sample Processing Technology from Spinomix

  - Applicable to a wide variety of sample types to isolate bacteria, viruses, tumor cells, etc.  - FibroTrap improves...


May 19, 2015, 03:00 ET Debiopharm International SA Announces Phase III Positive Results for Triptorelin 6-month Formulation in the Management of Central Precocious Puberty (CPP)

Triptorelin 6-month formulation phase III trial demonstrates good efficacy in terms of pituitary and gonadal suppression and in arresting or...


Apr 23, 2015, 02:30 ET Debiopharm International SA Initiates Clinical Phase II Study Evaluating Debio 1450 in Staphylococcal Skin Infections

Debiopharm International SA (Debiopharm), part of Debiopharm Group™, a Swiss-based global biopharmaceutical company, today...


Apr 23, 2015, 02:30 ET La société Debiopharm International SA lance une étude clinique de Phase II, destinée à évaluer l'action du Debio 1450 sur des infections staphylococciques de la peau

Un an après le début de la phase I, Debiopharm a annoncé le lancement d'une étude clinique de Phase II,...